Don’t expect good news when Gilead Sciences (NASDAQ: GILD) announces its first-quarter results on May 2. The big biotech has already set expectations quite low for 2017.
However, there are several factors that could determine whether Gilead meets those low expectations. Here are three things in particular for investors to watch when the company reports its results.
Image source: Getty Images.